Epstein-Barr virus frequency in primary central nervous system lymphomas in Turkey

APMIS

Volumn 121, Issue 3, 2013, Pages 232-238

  Saglam, Arzu ^a   Akyurek, Nalan ^b   Soylemezoglu, Figen ^a   Uner, Aysegul ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Central nervous system; Epstein Barr Virus; Lymphoma

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; OLIGONUCLEOTIDE; PROTEIN BCL 2; PROTEIN BCL 6;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CENTRAL NERVOUS SYSTEM LYMPHOMA; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; BRAIN; BRAIN NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, VIRAL; TURKEY; YOUNG ADULT;

EID: 84874192228     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2012.02961.x     Document Type: Article

References (35)

1. Feller AC, Diebold J. Lymphoma of the Central Nervous System. In: Feller AC, Diebold J, editors. Histopathology of Nodal and Extranodal Non-Hodgkin's Lymphoma. Berlin Heidelberg: Springer-Verlag, 2004: 330-4.
2. Kluin PM, Dedckert M, Ferry JA. Primary Diffuse Large B cell Lymphoma of the CNS. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. Who Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC, 2008: 240-1.
3. Ferracini R, Pileri S, Bergmann M, Sabattini E, Rigobello L, Gambacorta M, et al. Non-Hodgkin lymphomas of the central-nervous-system - clinicopathological and immunohistochemical study of 147 cases. Pathol Res Prac 1993;189:249-60.
4. Jellinger KA, Paulus W. Primary central-nervous-system lymphomas - an update. J Cancer Res Clin Oncol 1992;119:7-27.
5. Grote TH, Grosh WW, List AF, Wiley R, Cousar JB, Johnson DH. Primary lymphoma of the central nervous-system - a report of 20 cases and a review of the literature. Am J of Clin Oncol-Canc Clinical Trials 1989;12:93-100.
6. Bashir RM, Harris NL, Hochberg FH, Singer RM. Detection of Epstein-Barr virus in CNS lymphomas by insitu hybridization. Neurology 1989;39:813-7.
7. Nakhleh RE, Manivel JC, Copenhaver CM, Sung JH, Strickler JG. Insitu hybridization for the detection of Epstein-Barr-virus in central-nervous-system lymphomas. Cancer 1991;67:444-8.
8. Macmahon EME, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, et al. Epstein-Barr-virus in AIDS-related primary central-nervous-system lymphoma. Lancet 1991;338:969-73.
9. Chang KL, Flaris N, Hickey WF, Johnson RM, Meyer JS, Weiss LM. Brain lymphomas of immunocompetent and immunocompromised patients - study of the association with Epstein-Barr-virus. Mod Pathol 1993;6:427-32.
10. Nuckols JD, Liu K, Burchette JL, McLendon RE, Traweek ST. Primary central nervous system lymphomas: a 30-year experience at a single institution. Mod Pathol 1999;12:1167-73.
11. Guterman KSA, Hair LS, Morgello S. Epstein-Barr virus and AIDS-related primary central nervous system lymphoma. Viral detection by immunohistochemistry, RNA in situ hybridization and polymerase chain reaction. Clin Neuropathol 1996;15:79-86.
12. Camilleri-Broet S, Martin A, Moreau A, Angonin R, Henin D, Gontier MF, et al. Primary central nervous system lymphomas in 72 immunocompetent patients pathologic findings and clinical correlations. Am J Clin Pathol 1998;110:607-12.
13. Auperin I, Mikol J, Oksenhendler E, Thiebaut JB, Brunet M, Dupont B, et al. Primary central-nervous-system malignant non-hodgkins-lymphomas from HIV-infected and noninfected patients - expression of cellular-surface proteins and Epstein-Barr viral markers. Neuropathol Appl Neurobiol 1994;20:243-52.
14. Hochberg FH, Miller G, Schooley RT, Hirsch MS, Feorino P, Henle W. Central-nervous-system lymphoma related to Epstein-Barr virus. N Engl J Med 1983;309:745-8.
15. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964;1:702-3.
16. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 2007;38:1293-304.
17. Deyrup AT. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol 2008;39:473-83.
18. List AF, Greer JP, Cousar JP, Johnson DH, Greco FA, Volsky DJ, et al. Primary brain lymphoma in the immunocompetent host - relation to Epstein-Barr-virus. Mod Pathol 1990;3:609-12.
19. Geddes JF, Bhattacharjee MB, Savage K, Scaravilli F, McLaughlin JE. Primary cerebral lymphoma - a study of 47 cases probed for Epstein-Barr-virus genome. J Clin Pathol 1992;45:587-90.
20. Krogh-Jensen M, Johansen P, D'Amore F. Primary central nervous system lymphomas in immunocompetent individuals: histology, Epstein-Barr virus genome, Ki-67 proliferation index, p53 and bcl-2 gene expression. Leuk Lymphoma 1998;30:131-42.
21. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-82.
22. Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 2001;3:1-10.
23. Deckert M, Engert A, Bruck W, Ferreri AJ, Finke J, Illerhaus G, et al. Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia 2011;25:1797-807.
24. Ekenel M, DeAngelis LM. Treatment of primary central nervous system lymphoma. Curr Neurol Neurosci Rep 2007;7:191-9.
25. Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma - a surveillance, epidemiology, and end results analysis. Cancer 2002;95:1504-10.
26. Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. Aids/cancer study group. J Natl Cancer Inst 1996;88:675-9.
27. Deckert-Schluter M, Rang A, Wiestler OD. Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system. Acta Neuropathol 1998;96:157-62.
28. Rao CR, Jain L, Bhatia K, Laksmaiah KC, Shankar SK. Association of primary central nervous system lymphomas with the Epstein-Barr virus. Neurol India 2003;51:237-40.
29. Kitai R, Matsuda K, Adachi E, Saito Y, Nakajima T, Takeuchi H, et al. Epstein-Barr virus-associated primary central nervous system lymphoma in the Japanese population. Neurol Med Chir (Tokyo) 2010;50:114-8.
30. Hamiltondutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, et al. In-situ demonstration of Epstein-Barr-virus small rnas (EBER-1) in acquired immunodeficiency syndrome-related lymphomas - correlation with tumor morphology and primary site. Blood 1993;82:619-24.
31. Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007;110:972-8.
32. Nishihara H, Tateishi U, Itoh T, Nagashima K, Tanaka S. Immunohistochemical and gene rearrangement studies of central nervous system lymphomatoid granulomatosis. Neuropathology 2007;27:413-8.
33. Lucantoni C, De Bonis P, Doglietto F, Esposito G, Larocca LM, Mangiola A, et al. Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review. J Neurooncol 2009;94:235-42.
34. Gonzalez-Darder JM, Vera-Roman JM, Pesudo-Martinez JV, Cerda-Nicolas M, Ochoa E. Tumoral presentation of primary central nervous system lymphomatoid granulomatosis. Acta Neurochir (Wien) 2011;153:1963-70.
35. Kagawa K, Ishida T, Okada H. Primary central nervous system lymphomatoid granulomatosis: a case report. No Shinkei Geka 2011;39:883-9.